$2.5B
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | RVMD Revolution Medicines Inc | 1.5M | +0.0% | $281M | 11.1% |
| 2 | INSM Insmed Inc | 1.6M | +6.7% | $171M | 6.7% |
| 3 | CYTK Cytokinetics Inc | 1.6M | +0.0% | $136M | 5.4% |
| 4 | CVS Cvs Health Corp | 1.1M | +633.3% | $114M | 4.5% |
| 5 | EWTX Edgewise Therapeutics Inc | 2.0M | +25.0% | $81M | 3.2% |
| 6 | VERA Vera Therapeutics Inc | 1.8M | +9.4% | $75M | 3.0% |
| 7 | AXSM Axsome Therapeutics Inc. | 300,000 | +757.1% | $73M | 2.9% |
| 8 | CAH Cardinal Health Inc | 300,000 | +11.1% | $71M | 2.8% |
| 9 | ROIV Roivant Sciences Ltd | 2.0M | +0.0% | $71M | 2.8% |
| 10 | RYTM Rhythm Pharmaceuticals Inc | 550,000 | −8.3% | $61M | 2.4% |
| 11 | EW Edwards Lifesciences Corp | 625,000 | +267.6% | $57M | 2.2% |
| 12 | ALHC Alignment Healthcare Inc | 2.0M | −22.3% | $48M | 1.9% |
| 13 | MRK Merck & Co Inc | 350,000 | −17.6% | $45M | 1.8% |
| 14 | DGX Quest Diagnostics Inc | 200,000 | +233.3% | $42M | 1.7% |
| 15 | UNIQURE NV Uniqure Nv | 900,000 | +0.0% | $41M | 1.6% |
| 16 | SRRK Scholar Rock Hldg Corp | 750,000 | +50.0% | $41M | 1.6% |
| 17 | BSX Boston Scientific Corp | 900,000 | +63.6% | $38M | 1.5% |
| 18 | BRIGHTSPRING HEALTH SVCS INC Brightspring Health Svcs Inc | 550,000 | −56.0% | $38M | 1.5% |
| 19 | ABT Abbott Laboratories | 400,000 | — | $36M | 1.4% |
| 20 | UNH Unitedhealth Group Inc | 85,000 | — | $35M | 1.4% |
| 21 | LFST Lifestance Health Group Inc | 3.0M | −30.2% | $32M | 1.3% |
| 22 | NVS Novartis Ag | 200,000 | −20.0% | $31M | 1.2% |
| 23 | TNGX Tango Therapeutics Inc | 1.0M | +122.2% | $31M | 1.2% |
| 24 | THC Tenet Healthcare Corp | 165,000 | — | $31M | 1.2% |
| 25 | SYRE Spyre Therapeutics Inc | 325,000 | — | $29M | 1.1% |
| 26 | NVO Novo-Nordisk A S | 600,000 | — | $29M | 1.1% |
| 27 | DFTX Definium Therapeutics Inc | 550,000 | +37.5% | $26M | 1.0% |
| 28 | NBIX Neurocrine Biosciences Inc | 150,000 | +0.0% | $25M | 1.0% |
| 29 | REGN Regeneron Pharmaceuticals | 40,000 | −52.9% | $25M | 1.0% |
| 30 | BIIB Biogen Inc | 100,000 | +66.7% | $22M | 0.9% |
| 31 | TVTX Travere Therapeutics Inc | 375,000 | — | $21M | 0.8% |
| 32 | LNTH Lantheus Hldgs Inc | 190,000 | +52.0% | $21M | 0.8% |
| 33 | GKOS Glaukos Corp | 150,000 | −14.3% | $21M | 0.8% |
| 34 | ORIC Oric Pharmaceuticals Inc | 1.9M | +35.7% | $21M | 0.8% |
| 35 | BBIO Bridgebio Pharma Inc | 275,000 | +0.0% | $20M | 0.8% |
| 36 | VERTEX PHARMACEUTICALS INC Vertex Pharmaceuticals Inc | 40,000 | +0.0% | $20M | 0.8% |
| 37 | ALMS Alumis Inc | 700,000 | −12.5% | $20M | 0.8% |
| 38 | ELV Elevance Health Inc Formerly | 50,000 | −33.3% | $19M | 0.8% |
| 39 | CNC Centene Corp Del | 300,000 | −53.8% | $19M | 0.8% |
| 40 | ERAS Erasca Inc | 1.0M | +42.9% | $18M | 0.7% |
| 41 | LLY Eli Lilly & Co | 15,000 | +0.0% | $18M | 0.7% |
| 42 | ARWR Arrowhead Pharmaceuticals In | 200,000 | −33.3% | $16M | 0.6% |
| 43 | NVST Envista Holdings Corporation | 600,000 | +71.4% | $16M | 0.6% |
| 44 | MDT Medtronic Plc | 200,000 | — | $16M | 0.6% |
| 45 | WATERS CORP Waters Corp | 40,000 | — | $15M | 0.6% |
| 46 | LIVN Livanova Plc | 180,000 | +20.0% | $15M | 0.6% |
| 47 | FORTE BIOSCIENCES INC Forte Biosciences Inc | 675,000 | +350.0% | $14M | 0.6% |
| 48 | MDGL Madrigal Pharmaceuticals Inc | 25,000 | +0.0% | $13M | 0.5% |
| 49 | PRAX Praxis Precision Medicines I | 40,000 | +0.0% | $13M | 0.5% |
| 50 | ANRO Alto Neuroscience Inc | 500,000 | +0.0% | $13M | 0.5% |